|
Pfizer Statement On Compensation To First Group Of Qualified
Claimants Of Trovan Fund
Newsdiaryonline Thur Aug 11,2011
Kano State Gov Rabiu Kwankwaso
NEW YORK -
Pfizer Inc. released the following statement today in reaction
to the payment made to four qualified claimants of the
Healthcare/Meningitis Trust Fund.
“We are pleased that these four individuals, the first group of
qualified claimants of the Healthcare/Meningitis Trust Fund,
have received compensation. This is the first step in a
multiphase review process by which the independent Board of
Trustees that manages the Fund will deliver payment to all other
qualified claimants.
“We congratulate the Board on reaching another milestone in the
implementation of the settlement agreement reached by Kano State
and Pfizer. We thank them for their commitment and dedication to
seeing this process through in the most timely and transparent
way possible.”
The independent, six-member Board of Trustees that manages the
Healthcare/Meningitis Trust Fund continues the process of
reviewing at least 547 claims to determine the eligibility of
claimants. Despite the number of claims, there were only 200
participants in the 1996 Trovan clinical trial.
Under the July 2009 settlement agreement, the Board - not Pfizer
or the Kano State government - will make the final
determinations on eligibility of the claimants and, if
applicable, the level of financial support they will receive.
|
